# C_2008319EN.01002601.xml

| 13.12.2008 | EN | Official Journal of the European Union | C 319/26 |
| --- | --- | --- | --- |

13.12.2008

EN

Official Journal of the European Union

C 319/26

---

Re-notification of a previously notified concentration

(Case COMP/M.5253 — Sanofi-Aventis/Zentiva)

(Text with EEA relevance)

(2008/C 319/12)

| 1. | On 5 September 2008, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 by which the undertaking Sanofi-Aventis Europe, société par actions simplifiée (France), belonging to the Sanofi-Aventis group (France), acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Zentiva N.V. (the Netherlands) by way of a public bid announced on 11 July 2008. |
| --- | --- |

1.

On 5 September 2008, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 by which the undertaking Sanofi-Aventis Europe, société par actions simplifiée (France), belonging to the Sanofi-Aventis group (France), acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Zentiva N.V. (the Netherlands) by way of a public bid announced on 11 July 2008.

société par actions simplifiée

| 2. | The business activities of the undertakings concerned are:






  — | for Sanofi-Aventis: research, development, manufacturing and marketing of pharmaceuticals and human vaccines, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Sanofi-Aventis: research, development, manufacturing and marketing of pharmaceuticals and human vaccines,

| — | for Zentiva: development, manufacturing and marketing of branded generic pharmaceuticals. |
| --- | --- |

—

for Zentiva: development, manufacturing and marketing of branded generic pharmaceuticals.

| 3. | This notification has been declared incomplete on 2 October 2008. The undertakings concerned have now provided the further information required. The notification became complete within the meaning of Article 10(1) of Council Regulation (EC) No 139/2004 on 5 December 2008. |
| --- | --- |

3.

This notification has been declared incomplete on 2 October 2008. The undertakings concerned have now provided the further information required. The notification became complete within the meaning of Article 10(1) of Council Regulation (EC) No 139/2004 on 5 December 2008.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.5253 — Sanofi-Aventis/Zentiva, to the following address:





  Commission of the European Communities |
| --- | --- |
| Competition DG |
| Merger Registry |
| Rue Joseph II/Jozef II-straat 70 |
| B-1000 Brussels |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.5253 — Sanofi-Aventis/Zentiva, to the following address:

Commission of the European Communities

Competition DG

Merger Registry

Rue Joseph II/Jozef II-straat 70

B-1000 Brussels

---